Transparency data

Non-tech. summaries 2014: projects on the endocrine system

Projects granted during 2014 that have a primary purpose of basic research into the endocrine system and metabolism.

Documents

Non-technical summaries: projects granted in 2014, volume 15

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gsi.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2014 with a primary purpose of basic research: endocrine system and metabolism.

The following projects were granted:

  • regulation of pituitary physiology (pituitary, gene regulation, prolactin)

  • genetics of metabolism (diabetes, obesity, diabetic complications, ageing)

  • the aetiology of metabolic disorders (diabetes, obesity, insulin secretion, channelopathy)

  • islet pretreatment to reduce hypoxic graft damage (diabetes, islets, transplantation, hypoxia)

  • oral delivery of test agents (oral gavage, diabetes therapy)

  • neuroplasticity, immunity and behaviour (rodent, seasonality, leukocytes, reproduction, neuroangiogenesis)

  • metabolic alterations of pregnancy (pregnancy, metabolic disease, offspring, therapies)

  • modulation of endocrine pathways by imprinted genes (Imprinting, hormones, development, epigenetics, metabolic)

  • relationship between diabetes and cancer (diabetes, cancer, pancreatitis)

  • energy homeostasis and metabolism (food intake, energy expenditure, obesity)

  • effects of mitochondrial functioning on mammal phenotype (endothermy, BAT, oxidative stress, rodents)

  • nuclear envelope roles in health and disease (nuclear envelope, genorne organ isation, metabolism 5 years)

  • the role of copper in diabetes and ageing (arteries, kidney, heart, eyes, biomarkers, treatment)

  • the role of NPPC in pituitary development (C-type natriuretic peptide (CNP), genetic modification tissue specific, mouse)

  • genetic toxicology: chemicals (mutagen, genetic toxicology)

  • impact of gut microbiota on type II diabetes (microbiota, metabolism, type II diabetes, obesity)

Published 25 April 2016